HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Polyisoprenylated benzophenones from Clusiaceae: potential drugs and lead compounds.

Abstract
Many new polyisoprenylated benzophenones with a bicyclo[3.3.1]-nonane-2,4,9-trione core structure have been isolated from plants in the Clusiaceae family, and their potent biological properties have been the subject of several studies. This review summarizes the biological activities reported for these secondary metabolites including cytotoxic, antimicrobial, antioxidant, and anti-inflammatory activities. Our efforts during the past years have foremost been directed towards isolating new polyisoprenylated benzophenones, as well as understanding the possible target and mechanism of action through which these compounds arrest cancer cells and inhibit the progression of the cell-cycle. The transcription of genes is affected in cancer cells treated with polyisoprenylated benzophenones; the oncogene c-Myb is down-regulated and endoplasmatic stress genes XBP1, ATF4, and DDIT3/CHOP are turned on. Consequently, the expression of iNOS and cell cycle regulators such as cyclin D and E are reduced. Evidence presented by independent investigators suggests that polyisoprenylated benzophenones affect the mediators in the Akt/mTOR stress pathway, although the specific target remains to be discovered. In addition, benzophenones isolated from plants display high antioxidant capacity and protect cells from oxidative stress and the formation of ROS involved during the inflammatory process. Since antiviral activity was initially reported for guttiferone A, potent synthetic analogues have been developed as effective new non-nucleoside reverse transcriptase inhibitors (NNRTI) to treat drug resistant HIV-1. In addition, benzophenones exert antimicrobial effects particularly against MRSA. The structure-activity relationships of polyisoprenylated benzophenones from natural sources and those of synthetic analogues are included in this review. Absorption, metabolism, and elimination of benzophenones are also discussed.
AuthorsUlyana Muñoz Acuña, Nikola Jancovski, Edward J Kennelly
JournalCurrent topics in medicinal chemistry (Curr Top Med Chem) Vol. 9 Issue 16 Pg. 1560-80 ( 2009) ISSN: 1873-4294 [Electronic] United Arab Emirates
PMID19903162 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
Chemical References
  • Anti-Infective Agents
  • Antineoplastic Agents, Phytogenic
  • Benzophenones
Topics
  • Animals
  • Anti-Infective Agents (chemistry, pharmacology, therapeutic use)
  • Antineoplastic Agents, Phytogenic (chemistry, pharmacology, therapeutic use)
  • Benzophenones (chemistry, pharmacology, therapeutic use)
  • Clusiaceae (chemistry)
  • Drug Evaluation, Preclinical
  • Humans

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: